Stay updated with breaking news from Eric Aboagye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A £32 million total-body positron emission tomography (PET) imaging platform for drug discovery, the UK’s first-of-its-kind and supported through the UKRI Infrastructure fund, has been launched via a partnership between the Medicines Discovery Catapult (MDC), the Medical Research Council (MRC) and Innovate UK. Click to read more...
Dr Miriam Stoppard on why some patients respond better to ovarian cancer treatment than others, and how this finding could help treat sufferers accordingly via a non-invasive test
New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.
/PRNewswire/ -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a developer of a world-class platform of radiopharmaceutical products for...
Radiopharm Theranostics Ltd (ASX:RAD) has welcomed the release of Imperial College London's F-18 Pivalate (RAD 101) Phase 2a data in patients with brain...